Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 3. Comparative clinical experience and new therapeutic applications.

[1]  K. Luomanmäki,et al.  Alprenolol and propranolol in the treatment of hypertension: a comparative study. , 2009, Acta medica Scandinavica. Supplementum.

[2]  J. Tuomilehto,et al.  A comparative study of alprenolol and alpha-methyldopa respectively in combination with chlorthalidone in hypertension. , 2009, Acta medica Scandinavica. Supplementum.

[3]  H. Isomäki,et al.  Alprenolol in the treatment of arrhythmias in acute coronary patients. , 2009, Acta medica Scandinavica.

[4]  E. Sandøe,et al.  Propranolol (inderal) in the long term prophylaxis of ventricular arrhythmias. , 2009, Acta medica Scandinavica.

[5]  J. Waterhouse,et al.  Are breast-fed babies still getting a raw deal in hospital? , 1979, British medical journal.

[6]  W. Frishman,et al.  Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 2. Physiologic and metabolic effects. , 1979, American heart journal.

[7]  W. Frishman.  Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 1. Pharmacodynamic and pharmacokinetic properties. , 1979, American heart journal.

[8]  C. Puliafito,et al.  Clinical trial comparing timolol ophthalmic solution to pilocarpine in open-angle glaucoma. , 1978, American journal of ophthalmology.

[9]  S D Shorvon,et al.  ONE DRUG FOR EPILEPSY , 1978, British medical journal.

[10]  W. Wiersinga,et al.  The influence of beta-adrenoceptor blocking agents on plasma thyroxine and triiodothyronine. , 1977, The Journal of clinical endocrinology and metabolism.

[11]  J. Ferro,et al.  TREATMENT OF FAMILIAL ESSENTIAL MYOCLONUS WITH PROPRANOLOL , 1977, The Lancet.

[12]  T. Zimmerman,et al.  Timolol: A β-Adrenergic Blocking Agent for the Treatment of Glaucoma , 1977 .

[13]  T. J. Murray,et al.  Long-term therapy of essential tremor with propranolol. , 1976, Canadian Medical Association journal.

[14]  C. Dollery,et al.  The clinical pharmacology of beta-adrenoceptor-blocking drugs. , 1976, Progress in cardiovascular diseases.

[15]  E. Sellers,et al.  PROPRANOLOL-DECREASED NORADRENALINE EXCRETION AND ALCOHOL WITHDRAWAL , 1976, The Lancet.

[16]  O. Sjaastad,et al.  SHORT‐TERM CLINICAL TRIAL of PROPRANOLOL IN RACEMIC FORM (INDERAL), D‐PROPRANOLOL and PLACEBO IN MIGRAINE , 1976, Acta neurologica Scandinavica.

[17]  J. Growdon,et al.  Beta-adrenergic mechanisms in action tremor. , 1975, The New England journal of medicine.

[18]  J. K. Nelson,et al.  Comparative trial of propranolol and practolol in hyperthyroidism. , 1975, British journal of clinical pharmacology.

[19]  I. Ramsay.  Adrenergic beta-receptor blockade in hyperthyroidism. , 1975, British Journal of Clinical Pharmacology.

[20]  Sklar Sh.  Letter: Herpes simplex. , 1975, Lancet.

[21]  G. L. Noel,et al.  Failure of propranolol to alter thyroid iodine release, thyroxine turnover, or the TSH and PRL responses to thyrotropin-releasing hormone in patients with thyrotoxicosis. , 1975, The Journal of clinical endocrinology and metabolism.

[22]  A. Wood,et al.  Pindolol in hypertension: twice-daily versus thrice-daily dosage. , 1975, Medical Journal of Australia.

[23]  E. Sowton,et al.  Effect of new beta-adrenergic blocking agent, Atenolol (Tenormin), on pain frequency, trinitrin consumption, and exercise ability. , 1975, British medical journal.

[24]  L. Hansson,et al.  Controlled study of atenolol in treatment of hypertension. , 1975, British medical journal.

[25]  E. Frohlich,et al.  A comparison of timolol and propranolol in essential hypertension. , 1975, American heart journal.

[26]  C. Regårdh,et al.  Plasma levels and effects of metoprolol on blood pressure and heart rate in hypertensive patients after an acute dose and between two doses during long‐term treatment , 1975, Clinical pharmacology and therapeutics.

[27]  A. Amery,et al.  Predictive value of various parameters for the antihypertensive effect of the beta blocker ICI 66,082 (1). , 1975, Archives internationales de pharmacodynamie et de therapie.

[28]  C. Havard,et al.  Propranolol in the Control of Schizophrenic Symptoms , 1974, British medical journal.

[29]  H. Vallin,et al.  Effect of a new beta-adrenergic blocking agent, ICI 66o82, on exercise haemodynamics and airway resistance in angina pectoris. , 1974, British heart journal.

[30]  J. Jefferson.  Beta-adrenergic receptor blocking drugs in psychiatry. , 1974, Archives of General Psychiatry.

[31]  M. Anttila,et al.  Antihypertensive effects of practolol and sotalol , 1974, Clinical pharmacology and therapeutics.

[32]  J. Petrie,et al.  Practolol and bendrofluazide in treatment of hypertension. , 1974, British heart journal.

[33]  S. Fo,et al.  Pindolol: a comparison with other antihypertensive drugs and a double-blind placebo trial. , 1974 .

[34]  R. Young,et al.  Efficacy of chronic propranolol therapy in action tremors of the familial, senile or essential varieties. , 1974, The New England journal of medicine.

[35]  B. Lewis,et al.  Acebutolol in cardiac arrhythmias , 1974, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[36]  C. Wilhelmsson,et al.  Comparative study of alprenolol and methyldopa in previously untreated essential hypertension. , 1973, British heart journal.

[37]  C. Oakley,et al.  Double-blind trial of propranolol and practolol in hypertrophic cardiomyopathy. , 1973, British heart journal.

[38]  H. J. Grosz,et al.  Effect of propranolol on active users of heroin. , 1973, Lancet.

[39]  E. Freis,et al.  Antihypertensive and Hemodynamic Properties of the New Beta Adrenergic Blocking Agent Timolol , 1973, Circulation.

[40]  R. Coffey,et al.  The Use of Propranofof In the Surgical Treatment of Thyrotoxic Patients , 1973, Annals of surgery.

[41]  P. Nestel,et al.  Evaluation of practolol in hypertension. Effects on sympathetic nervous system and renin responsiveness. , 1973, British heart journal.

[42]  Horn Me,et al.  Variable dose comparative trial of propranolol and sotalol in angina pectoris. , 1973 .

[43]  G. Nyberg,et al.  Comparison of two adrenergic beta-receptor blocking agents, alprenolol and propranolol, in treatment of angina pectoris. , 1973, British heart journal.

[44]  B. Scazziga,et al.  Effect of pindolol, a beta receptor antagonist, in hyperthyroidism , 1973, Clinical pharmacology and therapy.

[45]  D. Harrison,et al.  Acute haemodynamic effects of practolol in patients with idiopathic hypertrophic subaortic stenosis. , 1973, British heart journal.

[46]  P. Jacobs.  Paget's Disease in a Five-year-old , 1972 .

[47]  H. J. Grosz,et al.  Narcotic withdrawal symptoms in heroin users treated with propranolol. , 1972, Lancet.

[48]  G. Sandler,et al.  Clinical evaluation of oxprenolol in angina pectoris. , 1972, British heart journal.

[49]  A. Castellanos,et al.  Use of alprenolol in acute cardiac arrhythmias. , 1972, The American journal of cardiology.

[50]  J. Vickers,et al.  Propranolol in hypertension: a study of long-term therapy, 1964-1970. , 1972, American heart journal.

[51]  L. Storstein.  LB-46, a new beta-adrenergic receptor blocking agent in cardiac arrhythmias. , 1972, Acta medica Scandinavica.

[52]  W. Aronow,et al.  Treatment of arrhythmias with pindolol , 1972, Clinical pharmacology and therapeutics.

[53]  H. Waal-Manning,et al.  Practolol treatment in asthmatics. , 1971, Lancet.

[54]  P. Gillam,et al.  Assessment of propranolol in angina pectoris. Clinical dose response curve and effect on electrocardiogram at rest and on exercise. , 1971, British heart journal.

[55]  E. Sowton,et al.  Double-blind three-dose trial of oral alprenolol in angina pectoris. , 1971, British heart journal.

[56]  L. Dexter,et al.  Effects of beta blockade on the peripheral manifestations of thyrotoxicosis. , 1971, Annals of internal medicine.

[57]  L. Dexter,et al.  The enhanced myocardial contractility of thyrotoxicosis. Role of the beta adrenergic receptor. , 1971, Annals of internal medicine.

[58]  G. Levey.  Catecholamine sensitivity, thyroid hormone and the heart: A reevaluation , 1971 .

[59]  D. Shand,et al.  Plasma Propranolol Levels Associated with Suppression of Ventricular Ectopic Beats , 1971, British medical journal.

[60]  G. Sandler,et al.  Use of Oxprenolol in Cardiac Arrhythmias Associated with Acute Myocardial Ischaemia , 1971, British medical journal.

[61]  R. Kerber,et al.  Treatment of atrial arrhythmias with alprenolol. , 1970, JAMA.

[62]  W. Parmley,et al.  Clinical evaluation of the antiarrhythmic effects of Sotalol® (MJ 1999) , 1970 .

[63]  J. Thirkettle,et al.  Controlled Trial of Oxprenolol and Practolol in Hypertension , 1970, British medical journal.

[64]  D. Shand,et al.  Plasma Propranolol Levels in the Quantitative Assessment of β-adrenergic Blockade in Man , 1970, British medical journal.

[65]  B. Joffe,et al.  The use and abuse of beta-adrenergic blockade in the surgery of hyperthyroidism. , 1970, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[66]  P. Turner.  Alprenolol and propranolol in hyperthyroid tachycardia. , 1970, British journal of pharmacology.

[67]  J. Hickie.  ALPRENOLOL (“APTIN”) IN ANGINA PECTORIS A DOUBLE–BUND MULTICENTRE TRIAL , 1970, The Medical journal of Australia.

[68]  J. Goodwin.  Congestive and hypertrophic cardiomyopathies. A decade of study. , 1970, Lancet.

[69]  F. Zacharias,et al.  Controlled Trial of Propranolol in Hypertension , 1970, British medical journal.

[70]  G. Nyberg,et al.  Prophylactic Treatment of Angina Pectoris. A Double-Blind Cross-Over Comparison of Alprenolol and Pentanitrol , 1970, British medical journal.

[71]  Pimstone Bl.  Beta-adrenergic blockade in thyrotoxicosis. , 1969 .

[72]  C. Dollery,et al.  Clinical pharmacology of beta‐receptor‐blocking drugs , 1969, Clinical pharmacology and therapeutics.

[73]  J. Shillingford,et al.  Comparison of drugs used in management of arrhythmias developing after acute myocardial infarction. , 1969, British heart journal.

[74]  J. Shillingford,et al.  Hemodynamic effects of ouabain in patients with acute myocardial infarction studies with an electromagnetic velometer. , 1969, British heart journal.

[75]  S. Epstein,et al.  Myocardial adenyl cyclase: activation by thyroid hormones and evidence for two adenyl cyclase systems. , 1969, The Journal of clinical investigation.

[76]  D. Hadden,et al.  Controlled trial of propranolol in thyrotoxicosis. , 1969, Lancet.

[77]  G. Das,et al.  Treatment of thyrotoxic storm with intravenous administration of propranolol. , 1969, Annals of internal medicine.

[78]  D. Spodick,et al.  Control of persistent ventricular ectopic beats by alprenolol, a new beta-adrenergic blocking agent. , 1969, American heart journal.

[79]  J. S. Peel,et al.  Trasicor in Angina Pectoris: a Double-blind Trial , 1969, British medical journal.

[80]  P. Gillam,et al.  Treatment of Hypertension with Propranolol , 1969, British medical journal.

[81]  E. O. Theilen,et al.  Beta-adrenergic receptor blocking drugs in the treatment of cardiac arrhythmias. , 1968, The Medical clinics of North America.

[82]  P. Turner,et al.  A comparison of three beta-adrenergic receptor-blocking drugs in thyrotoxic tachycardia. , 1968, The Journal of clinical pharmacology and the journal of new drugs.

[83]  G. Humphreys,et al.  Ineffectiveness of propranolol in hypertensive Jamaicans. , 1968, British medical journal.

[84]  H. Ikram.  Propranolol in persistent ventricular fibrillation complicating acute myocardial infarction. , 1968, American heart journal.

[85]  G. Sloman,et al.  Beta-adrenergic blockade and cardiac arrhythmias. , 1967, British medical journal.

[86]  B. Surawicz,et al.  ORIGINAL ARTICLES: LONG‐TERM PREVENTION OF PAROXYSMAL ARRHYTHMAIAS WITH PROPRANOLOL THERAPY , 1967 .

[87]  C D Marsden,et al.  Peripheral beta-adrenergic receptors concerned with tremor. , 1967, Clinical science.

[88]  P. Turner,et al.  The effect of propranolol on anxiety. , 1966, Lancet.

[89]  R. Taylor,et al.  Beta‐Adrenergic Blockade in the Treatment of Exercise‐Induced Paroxysmal Ventricular Tachycardia , 1965, Circulation.

[90]  J. Robinson,et al.  Propranolol (Inderal) in Persistent Ventricular Fibrillation , 1965, British medical journal.

[91]  D. Rowlands,et al.  Propranolol (Inderal) in Disturbances of Cardiac Rhythm , 1965, British medical journal.

[92]  E. O. Theilen,et al.  PHARMACODYNAMIC EFFECTS OF BETA-ADRENERGIC RECEPTOR BLOCKADE IN PATIENTS WITH HYPERTHYROIDISM. , 1964, The Journal of clinical investigation.

[93]  L. Es.  NEW LIBRARIES FOR OLD. , 1964 .

[94]  J. P. Isaacs,et al.  The Hemodynamic and Metabolic Interrelationships in the Activity of Epinephrine, Norepinephrine and the Thyroid Hormones , 1956, Circulation.

[95]  K. Donald,et al.  Definition and Assessment of Respiratory Function* , 1953, British medical journal.

[96]  E. Degowin,et al.  A case of infection with brucella sius, causing endocarditis and nephritis; Death from rupture of mycotic aneurysm , 1945 .

[97]  W. Humble.  ABDOMINAL TUMOUR OBSTRUCTING DELIVERY. , 1853 .

[98]  J. H. Baron.  Letter: Montezuma's revenge. , 1976, Lancet.

[99]  R. Santangelo,et al.  Metabolic effects of propranolol in thyrotoxicosis. I. Nitrogen, calcium, and hydroxyproline. , 1975, Metabolism: clinical and experimental.

[100]  C. Tiwary.  Letter: Testosterone, L.H.R.H., and behaviour. , 1974, Lancet.

[101]  C. Oakley,et al.  Beta-adrenergic blockade in patients with hypertrophic obstructive cardiomyopathy. , 1967, American Heart Journal.